Trial intelligence / Profile preview

Patiromer and Tacrolimus Interaction in Renal Transplant

NCT05029310Phase 4Completed

Sponsor
Oslo University Hospital
Start
Sep 2021
Primary completion
Feb 2023
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of patiromer in hyperkalemia, sponsored by Oslo University Hospital. Started Sep 2021; status: completed.

02

Drugs

patiromer
03

Conditions

hyperkalemia

Beyond the preview

Go deeper on NCT05029310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05029310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call